|
Mechanismprolactin antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanismprolactin antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Antibody Design Labs
0 Patents (Medical) associated with Antibody Design Labs
100 Deals associated with Antibody Design Labs
100 Translational Medicine associated with Antibody Design Labs